| 1. |
|
|
| 2. |
- Clark, M. S., et al.
(author)
-
Multi-omics for studying and understanding polar life
- 2023
-
In: Nature Communications. - : NATURE PORTFOLIO. - 2041-1723. ; 14
-
Journal article (peer-reviewed)abstract
- Polar ecosystems are experiencing amongst the most rapid rates of regional warming on Earth. Here, we discuss ‘omics’ approaches to investigate polar biodiversity, including the current state of the art, future perspectives and recommendations. We propose a community road map to generate and more fully exploit multi-omics data from polar organisms. These data are needed for the comprehensive evaluation of polar biodiversity and to reveal how life evolved and adapted to permanently cold environments with extreme seasonality. We argue that concerted action is required to mitigate the impact of warming on polar ecosystems via conservation efforts, to sustainably manage these unique habitats and their ecosystem services, and for the sustainable bioprospecting of novel genes and compounds for societal gain.
|
|
| 3. |
- Karlsson, Lene, et al.
(author)
-
Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia
- 2023
-
In: British Journal of Haematology. - : Wiley. - 0007-1048 .- 1365-2141. ; 201:4, s. 757-765
-
Journal article (peer-reviewed)abstract
- A significant proportion of events in paediatric acute myeloid leukaemia (AML) are caused by resistant disease (RD). We investigated clinical and biological characteristics in 66 patients with RD from 1013 children with AML registered and treated according to the NOPHO-AML 93, NOPHO-AML 2004, DB AML-01 and NOPHO-DBH AML 2012 protocols. Risk factors for RD were age10 years or older and a white-blood-cell count (WBC) of 100 x 10(9)/L or more at diagnosis. The five-year overall survival (OS) was 38% (95% confidence interval [CI]: 28%-52%). Of the 63 children that received salvage therapy with chemotherapy, 59% (N = 37) achieved complete remission (CR) with OS 57% (95% CI: 42%-75%) compared to 12% (95% CI: 4%-35%) for children that did not achieve CR. Giving more than two salvage chemotherapy courses did not increase CR rates. OS for all 43 patients receiving allogeneic haematopoietic stem cell transplantation (HSCT) was 49% (95% CI: 36%-66%). Those achieving CR and proceeding to HSCT had an OS of 56% (95% CI: 41%-77%, N = 30). This study showed that almost 40% of children with primary resistant AML can be cured with salvage therapy followed by HSCT. Children that did not achieve CR after two salvage courses with chemotherapy did not benefit from additional chemotherapy.
|
|
| 4. |
- Kro, G A B, et al.
(author)
-
A new tool for the validation of umbilical cord acid-base data.
- 2010
-
In: BJOG : an international journal of obstetrics and gynaecology. - : Wiley. - 1471-0528 .- 1470-0328. ; 117:12, s. 1544-52
-
Journal article (peer-reviewed)abstract
- To identify the distribution of carbon dioxide tension (pCO(2) ) relative to pH in validated umbilical cord acid-base data.
|
|
| 5. |
|
|
| 6. |
- Berg, M, et al.
(author)
-
A compact range telescope for K+ measurements
- 1996
-
In: NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT. - 0168-9002. ; 381:2-3, s. 267-274
-
Journal article (peer-reviewed)abstract
- We present range telescopes for measurements of low energy K+ mesons together with first in-beam results. The hardware trigger, based on the observation of the mu(+) from the K+ --> mu(-) + nu(mu) decay channel, is designed for subthreshold hadron-nucleus
|
|
| 7. |
- Elmer, R, et al.
(author)
-
K+ emission in symmetric heavy ion reactions at subthreshold energies
- 1996
-
In: PHYSICAL REVIEW LETTERS. - : AMER INST PHYSICS. ; 77:24, s. 4884-4886
-
Journal article (peer-reviewed)abstract
- Subthreshold K+ production cross sections have been measured in symmetric Ne + NaF, Ni + Ni, and Au + Au collisions at 1.0A GeV. The mass dependence is strong, close to A(2). The angular distributions are nonisotropic in the center-of-mass system. Introdu
|
|
| 8. |
- Espersen, A. D. L., et al.
(author)
-
Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature
- 2018
-
In: Genes Chromosomes & Cancer. - : Wiley. - 1045-2257 .- 1098-2264. ; 57:7, s. 359-365
-
Journal article (peer-reviewed)abstract
- The t(7;12)(q36;p13) (MNX1/ETV6) is not included in the WHO classification but has been described in up to 30% of acute myeloid leukemia (AML) in children <2 years and associated with a poor prognosis. We present the clinical and cytogenetics characteristics of AML cases with t(7;12)(p36;p13). A literature review identified 35 patients with this translocation, published between 2000 and 2015. Outcome data were available in 22 cases. The NOPHO-AML (Nordic Society for Pediatric Hematology and Oncology) database contained 651 patients with AML from 1993 to 2014 and seven (1.1%) had the translocation. The t(7;12) was only present in patients <2 years of age (median age 6 months) but none was diagnosed as newborn. These patients constituted 4.3% of the patients <2 years of age. There was a strong association with trisomy 19 (literature: 86%, NOPHO: 100%) and +8 (literature: 19%, NOPHO: 14%). Seventeen of 22 patients from the literature with t(7;12) and four of seven patients from the NOPHO database suffered from relapse. The patients with t(7;12) had a 3-year event free survival of 24% (literature) vs. 43% (NOPHO) and a 3-year overall survival of 42% (literature) vs. 100% (NOPHO). None of the NOPHO patients was treated with hematopoietic stem cell transplantation (HSCT) in first complete remission. Relapse was frequent but the salvage rate using HSCT was high. We conclude that t(7;12)(q36;13) is a unique subgroup of childhood AML with presentation before 2 years of age with most cases being associated with +19.
|
|
| 9. |
|
|
| 10. |
|
|
